NR0B2 c.46A>T ;(p.S16C)

Variant ID: 1-27240386-T-A

NM_021969.2(NR0B2):c.46A>T;(p.S16C)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor.

Hepatology (Baltimore, Md.)
Xu, Wenjing W; Cui, Changting C; Cui, Chunmei C; Chen, Zhenzhen Z; Zhang, Haizeng H; Cui, Qinghua Q; Xu, Guoheng G; Fan, Jianglin J; Han, Yu Y; Tang, Liangjie L; Targher, Giovanni G; Byrne, Christopher D CD; Zheng, Ming-Hua MH; Yang, Liming L; Cai, Jun J; Geng, Bin B
Publication Date: 2022-12

Variant appearance in text: SHP: S16C
PubMed Link: 35586979
Variant Present in the following documents:
  • Main text
  • HEP-76-1794.pdf
View BVdb publication page